Suggest a Reference
Relevant citation suggestion(s) are very important to us. To enable us to review the addition of this reference, please give as much detail as possible.
If you have a query related to this product, please contact technical support.
Find multiple products by catalog number
Potent, selective LRRK2 inhibitor
Tocris is the first to launch GSK2578215A, licensed from GlaxoSmithKline, for the study of Parkinson's Disease.